Abstract
This investigation describes the expression and interindividual variability in transcript levels of multiple drug efflux systems in the human jejunum and compares the expression profiles in these cells with that of the commonly used Caco-2 cell drug absorption model. Transcript levels of ten-drug efflux proteins of the ATP-binding cassette (ABC) transporter family [MDR1, MDR3, ABCB5, MRP1–6, and breast cancer resistance protein (BCRP)], lung resistance-related protein (LRP), and CYP3A4 were determined using quantitative polymerase chain reaction in jejunal biopsies from 13 healthy human subjects and in Caco-2 cells. All genes except ABCB5 were expressed, and transcript levels varied between individuals only by a factor of 2 to 3. Surprisingly, BCRP and MRP2transcripts were more abundant in jejunum than MDR1transcripts. Jejunal transcript levels of the different ABC transporters spanned a range of three log units with the rank order: BCRP ≈ MRP2 > MDR1 ≈ MRP3 ≈ MRP6 ≈ MRP5 ≈ MRP1 > MRP4 > MDR3. Furthermore, transcript levels of 9 of 10 ABC transporters correlated well between jejunum and Caco-2 cells (r2 = 0.90). However,BCRP exhibited a 100-fold lower transcript level in Caco-2 cells compared with jejunum. Thus, the expression of a number of efflux protein transcripts in jejunum are equal to, or even higher than, that of MDR1, suggesting that the roles of these proteins (in particular BCRP and MRP2) in intestinal drug efflux have been underestimated. Also, we tentatively conclude that the Caco-2 cell line is a useful model of jejunal drug efflux, if the low expression of BCRP is taken into account.
Footnotes
-
This work was supported by grants from The Swedish Medical Research Council (Grant 9478), The Swedish National Board for Laboratory Animals (Grant 01-56), and Pharmacia, Sweden.
- Abbreviations:
- ABC
- ATP-binding cassette
- BCRP
- breast cancer resistance protein
- LRP
- lung resistance-related protein
- PCR
- polymerase chain reaction
- RT-PCR
- reverse transcription-PCR
- Received May 14, 2001.
- Accepted June 29, 2001.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|